FIELD: medicine, cardiology, chemical-pharmaceutical industry. SUBSTANCE: invention relates to development, production and using agents for treatment of patients with cardiovascular diseases. Agent has the following components. wt. -%: potassium glutamate, 4.42-5.36; magnesium glutamate, 3.98-4.94; propylene glycol, 3.00-10.00 and water for injection, up to 100. EFFECT: high level and broad spectrum of specific activity with simultaneous decrease or elimination of adverse effects and contraindications, broadened spectrum of prescription. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INFUSION SOLUTION TO TREAT CARDIOVASCULAR SYSTEM DISEASES | 2000 |
|
RU2178296C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
| ANTI-ISCHEMIC REMEDY POSSESSING ANTI-ARRHYTHMIC AND ANTI-ATHEROGENIC ACTIVITY AND METHOD FOR APPLYING THE MEANS | 2004 |
|
RU2259822C1 |
| N-1-[(4-FLUOROPHENYL)-2-(1-ETHYL-4-PIPERIDYL)-ETHYL]-4-NITROBENZAMIDE HYDROCHLORIDE EXHIBITING ANTIARHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 2009 |
|
RU2415128C2 |
| PHARMACEUTICAL COMPOSITION POSSESSING PROLONGED ANTIARRHYTHMIC ACTIVITY | 2012 |
|
RU2538674C2 |
| COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS ELICITING ANTIARRHYTHMIC ACTIVITY | 1999 |
|
RU2173553C2 |
| 2-(DIETHYLAMINO)-N-(2,6-DIMETHYLPHENYL)ACETAMIDE L-GLUTAMATE, HAVING PROLONGED ANTIARRHYTHMIC ACTIVITY, PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2697717C1 |
| METHOD TO OBTAIN INJECTION PREPARATION BASED UPON A SUBSTANCE OF P-VITAMIN ACTIVITY | 2001 |
|
RU2181051C1 |
| DELAYED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING ASPARAGINATES | 2016 |
|
RU2632713C2 |
| MEDICINAL AGENT "ASPARKAM-1" FOR REGULATION OF METABOLIC PROCESSES AND METHOD FOR ITS PREPARING | 2003 |
|
RU2229879C1 |
